RK
Rupam Kumari
About Rupam Kumari
Data last updated:
Rupam Kumari is a Director at Juneberry Healthcare Private Limited (since 2022) and Director at Espron Pharma Private Limited (since 2022). The companies operate in Healthcare and Home Appliances. The largest current company by reported revenue is Juneberry Healthcare Private Limited at ₹39.2 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Oct 2022 | 2020 | ₹39.2 Lakh (FY 2023) | Active | |
| Director | 22 Nov 2022 | 2022 | Active |
Board colleagues of Rupam Kumari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bindu Kumari | 08806669 | Juneberry Healthcare Private Limited | Director |
| Manisha Srivastava | 09461725 | Juneberry Healthcare Private Limited | Director |
| Sonam Kumari | 09256932 | Juneberry Healthcare Private Limited | Director |
| Prabhat Kumar | 08259123 | Espron Pharma Private Limited | Director |
| Sudhir Kumar | 09799097 | Espron Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rupam Kumari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rupam Kumari
Rupam Kumari currently holds 2 directorships: Juneberry Healthcare Private Limited (Director, since 01 Oct 2022, revenue ₹39.2 Lakh (FY 2023)); Espron Pharma Private Limited (Director, since 22 Nov 2022).
Rupam Kumari was first appointed on 01 Oct 2022 as Director at Juneberry Healthcare Private Limited.
The current boards of Rupam Kumari's companies include Bindu Kumari (Juneberry Healthcare Private Limited), Manisha Srivastava (Juneberry Healthcare Private Limited), Sonam Kumari (Juneberry Healthcare Private Limited), Prabhat Kumar (Espron Pharma Private Limited), Sudhir Kumar (Espron Pharma Private Limited).